Sotirimod

CAS: 227318-75-4

Ref. 3D-CJA31875

Produktinformation

• Name: Sotirimod

Beschreibung

Sotirimod is a monocytic degradable drug that has been shown to be effective in the treatment of skin cancer. It is also used as a diagnostic agent for prostate, colorectal, and breast cancer. Sotirimod binds to fatty acid molecules on the surface of cells. The drug then enters the cell where it forms crosslinks with DNA or RNA, which prevents cell division and replication. This causes cell death by apoptosis. Sotirimod can also be conjugated with affinity ligands such as antibodies or peptides to target specific types of cells.

• Marke: Biosynth

Chemische Eigenschaften

• Molekulargewicht: 255.32 g/mol
• Formel: C₁₄H₁₇N₅
• Reinheit: Min. 95%